Opioids for treating dyspnoea in patients with chronic heart failure
Editorial Group: Cochrane Heart Group
Published Online: 17 FEB 2014
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Shearer FA, Struthers AD, Harbour RT. Opioids for treating dyspnoea in patients with chronic heart failure (Protocol). Cochrane Database of Systematic Reviews 2014, Issue 2. Art. No.: CD010991. DOI: 10.1002/14651858.CD010991.
- Publication Status: New
- Published Online: 17 FEB 2014
This is the protocol for a review and there is no abstract. The objectives are as follows:
To assess whether opioid analgesics have a role in the control of dyspnoea in adults (aged 18 and over) with chronic heart failure. If the opioid reduces breathlessness in heart failure, this could potentially markedly improve the quality of life of people with this problem, as breathlessness is a major adverse symptom in heart failure. What is not entirely clear is whether opioids really do reduce breathlessness in heart failure and, if so, by how much and is it is enough to impact on quality of life?